DOSAGE DES GLYCOSIDES CARDIAQUES DANS LES MILIEUX BIOLOGIQUESBOLANOWSKA W.1976; POST. HIG. MED. DOSWIAD.; POLSKA; DA. 1976; VOL. 30; NO 1; PP. 133-144; ABS. RUSSE ANGL.; BIBL. 2 P. 1/2Article

BODY RESIDUE AND METABOLISM OF ADRIAMYCIN AND DAUNORUBICIN IN CONTROL AND PHENOBARBITAL-PRETREATED MICEBOLANOWSKA W; GESSNER T.1982; XENOBIOTICA; ISSN 0049-8254; GBR; DA. 1982; VOL. 12; NO 2; PP. 125-136; BIBL. 38 REF.Article

DRUG INTERACTIONS WITH ACETAMINOPHEN. EFFECTS OF PHENOBARBITAL, PREDNISONE AND 5-FLUOROURACIL IN NORMAL AND TUMOR-BEARING RATSBOLANOWSKA W; GESSNER T.1980; BIOCHEM. PHARMACOL.; GBR; DA. 1980; VOL. 29; NO 8; PP. 1167-1175; BIBL. 47 REF.Article

A SIMPLIFIED METHOD FOR DETERMINATION OF DAUNORUBICIN, ADRIAMYCIN, AND THEIR CHIEF FLUORESCENT METABOLITES IN HUMAN PLASMA BY HIGH-PRESSURE LIQUID CHROMATOGRAPHYBOLANOWSKA W; GESSNER T; PREISLER H et al.1983; CANCER CHEMOTHERAPY AND PHARMACOLOGY; ISSN 0344-5704; DEU; DA. 1983; VOL. 10; NO 3; PP. 187-191; BIBL. 29 REF.Article

ABSENCE OF SEASONAL VARIATION IN ANTIPYRINE METABOLISMPAIGEN B; WARD E; STEELAND K et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 2; PP. 144-150; BIBL. 25 REF.Article

EFFECTS OF PRIOR THERAPY IN PLASMA LEVELS OF ADRIAMYCIN DURING SUBSEQUENT THERAPYGESSNER T; ROBERT J; BOLANOWSKA W et al.1981; J. MED. (WESTBURY); ISSN 0025-7850; USA; DA. 1981; VOL. 12; NO 2-3; PP. 183-193; BIBL. 2 P.Article

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC ANALYSIS OF BENZO(A) PYRENE METABOLISM BY HUMAN LYMPHOCYTES FROM DONORS OF DIFFERENT ARYL HYDROCARBON HYDROXYLASES INDUCIBILITY AND ANTIPYRINE HALF-LIVESGURTOO HL; VAUGHT JB; MARINELLO AJ et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 4; PP. 1305-1310; BIBL. 50 REF.Article

Activation of mammalian folylpolyglutamate synthetase by sodium bicarbonateBOLANOWSKA, W. E; RUSSELL, C. A; MCGUIRE, J. J et al.Archives of biochemistry and biophysics (Print). 1990, Vol 281, Num 2, pp 198-203, issn 0003-9861, 6 p.Article

Biochemical and biological properties of methotrexate analogs containing D-glutamic acid or D-erythro,threo-4-fluoroglutamic acidMCGUIRE, J. J; BOLANOWSKA, W. E; COWARD, J. K et al.Biochemical pharmacology. 1991, Vol 42, Num 12, pp 2400-2403, issn 0006-2952Article

Synthesis and biological activity of folic acid and methotrexate analogues containing L-threo-(2S,4S)-4-fluoroglutamic acid and DL-3,3-difluoroglutamic acidHART, B. P; HAILE, W. H; LICATO, N. J et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 1, pp 56-65, issn 0022-2623Article

Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the γ-carboxyl groupMCGUIRE, J. J; RUSSELL, C. A; BOLANOWSKA, W. E et al.Cancer research (Baltimore). 1990, Vol 50, Num 6, pp 1726-1731, issn 0008-5472Article

Plasma levels of daunorubicin metabolites and the outcome of ANLL therapyGESSNER, T; PREISLER, H. D; AZARNIA, N et al.Medical oncology and tumor pharmacotherapy. 1987, Vol 4, Num 1, pp 23-31, issn 0736-0118Article

Synthesis of N-[N-(4-deoxy-4-amino-10-methylpteroyl)-4-fluoroglutamyl]-γ-glutamate, an unusual substrate for folylpoly-γ-glutamate synthetase and γ-glutamyl hydrolaseLICATO, N. J; COWARD, J. K; NIMEC, Z et al.Journal of medicinal chemistry (Print). 1990, Vol 33, Num 3, pp 1022-1027, issn 0022-2623Article

Biological properties of fluoroglutamate-containing analogs of folates and methotrexate with altered capacities to form poly (γ-glutamate) metabolitiesMCGUIRE, J. J; HART, B. P; HAILE, W. H et al.Biochemical pharmacology. 1996, Vol 52, Num 8, pp 1295-1303, issn 0006-2952Article

Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemiaPREISLER, H. D; GESSNER, T; JOYCE, R et al.Cancer chemotherapy and pharmacology. 1984, Vol 12, Num 2, pp 125-130, issn 0344-5704Article